Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Consulting Group Inc Biostrategies currently holds 17,508,334 shares of Enhance Skin Products Inc (EHSK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Consulting Group Inc Biostrategies has been a net neutral trader of EHSK stock. They have purchased $0 and sold $0 worth of shares.
Consulting Group Inc Biostrategies's most recent insider trade was on May 12, 2010, when they sold 825,000 shares at $0.00 per share.
Consulting Group Inc Biostrategies serves as Executive at Enhance Skin Products Inc (EHSK). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Consulting Group Inc Biostrategies holds the position of Executive at Enhance Skin Products Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
Consulting Group Inc Biostrategies has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Consulting Group Inc Biostrategies was on May 12, 2010, when they sold $0 worth of EHSK shares. This transaction involved 825,000 shares at N/A per share.
Consulting Group Inc Biostrategies currently owns 17,508,334 shares of Enhance Skin Products Inc (EHSK), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Consulting Group Inc Biostrategies's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Consulting Group Inc Biostrategies has 2 Form 4 filings on record as an insider at Enhance Skin Products Inc.
Set alerts for Consulting Group Inc Biostrategies and 40,000+ other insiders.